New technology that rapidly and simply detects disease-specific molecular alterations in two forms of leukemia could give ...

Six years ago, Sanofi gave $125 million and promised over $1 billion in milestone payments to buzzy neuroscience startup ...

Rapid blood cancer diagnostics enable faster decision-making, potentially saving lives by providing quicker, more accurate ...

A $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at the University of Pennsylvania (Penn) and Children's Hospital of ...

Using a form of CRISPR technology, the ultimate vision of the four-year ... This technology holds the promise of personalized treatments for patients with rare metabolic diseases such as type I ...

While rare in Britain, the genetic disorder places a major burden on healthcare systems in countries like Thailand and Laos ...

Seven young boys given Bluebird's Skysona later developed blood cancers, findings that could shape how doctors balance the gene therapy’s risks against its benefit.

New gene therapies developed using CRISPR gene editing offer the promise of treating or even curing debilitating diseases.

Prime Medicine's layoffs are part of a pattern. At least a half-dozen gene-editing companies have laid off staff in the past ...

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions.